Tracking how politics and policy influence health care and medicine. To get the latest delivered to your inbox, sign up for our free D.C. Diagnosis newsletter. And subscribe to STAT+ for inside intelligence on the intersection of Capitol Hill and the life sciences.
A new STAT analysis shows that more than two-thirds of Congress cashed a check from the pharmaceutical industry ahead of the 2020 election.
Read The Story
advertisement
